Serum β2 microglobulin in oral malignancy and premalignancy
- 1 October 1981
- journal article
- research article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 10 (5) , 354-357
- https://doi.org/10.1111/j.1600-0714.1981.tb01287.x
Abstract
Scrum β2 microglobulin concentrations measured by radioimmunoassay in patients with oral squamous cell carcinoma, or with oral keratosis and epithelial dysplasia, were found to be significantly increased compared with age and sex matched controls.This publication has 24 references indexed in Scilit:
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980
- Serum Levels of β2-Microglobulin — A New Marker of Activity in Crohn's DiseaseNew England Journal of Medicine, 1979
- Serum β2 microglobulin and its prognostic value in lymphomasPublished by Elsevier ,1979
- Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1978
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- Serum Beta-2-Microglobulin In Sjogren's SyndromeScandinavian Journal of Rheumatology, 1978
- β2-Microglobulin levels in cancerous and other disease statesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Aggregation of HL-A Antigens at the Lymphocyte Surface Induced by Antiserum to β 2 -MicroglobulinScience, 1973
- β 2 -Microglobulin: Association with Lymphocyte ReceptorsScience, 1973
- Presence of β2-Microglobulin on B- and T-Cells and Lymphocytotoxicity of Anti-β2-Microglobulin SeraImmunological Communications, 1973